Mirati Therapeutics (MRTX) PT Lowered to $42 at JPMorgan
Tweet
Share
E-mailGet Alerts MRTX Hot Sheet
Price: $58.70 --0%
Rating Summary:
8 Buy, 18 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 15 | Down: 9 | New: 6
Rating Summary:
8 Buy, 18 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 15 | Down: 9 | New: 6
Join SI Premium – FREE
JPMorgan analyst Eric Joseph lowered the price target on Mirati Therapeutics (NASDAQ: MRTX) to $42.00 (from $53.00) while maintaining a Neutral rating.
You May Also Be Interested In
- Coherent (COHR) PT Raised to $420 at Needham
- Nexxen (NEXN) PT Raised to $13 at Canaccord
- Entergy Corp (ETR) PT Lowered to $122 at Truist Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
